Posted by Michael Wonder on 13 Oct 2016
Drugs and manners of administration that meet the F2/multi-brand criteria (30 month clock for originator removal calculation) for the 2017 April Cycle
14 October 2016 - A list of drugs and manners of administration that meet the F2/multi-brand criteria (30 month clock for originator removal calculation) for the 2017 April cycle of price disclosure have now been published.
In general, originator removal calculations will apply to price disclosure data submitted for the data collection period commencing 1 October 2015 when a drug has been on F2 for at least 2.5 years (30 months), with:
- calculations for originator removal being at least 3 years (36 months) after the drug has been on F2; and
- the reduction day for originator removed calculations being at least 3.5 years (42 months) after movement to F2.
Once a drug/MoA has met the 30 month clock it will have an originator removal calculation performed in each price disclosure cycle thereafter.
